Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-13

Clinical Trial Update: Vitamin K as Additive Treatment in Osteoporosis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update investigating vitamin K as an additive treatment for post-menopausal osteoporosis across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin K (Vitamin K)

Snippet

Sponsor: Guy's and St Thomas' NHS Foundation Trust | Conditions: Post-menopausal Osteoporosis | Phase 2, Phase 3 | Status: UNKNOWN